“…[14] Commercially important drugss uch as MK-4827 (anticancer activity) [15] and pazopanib (tyrosinek inase inhibitor,v otrient) [16,17] incorporate indazole as ab asic scaffold.Functionalization of 2H-indazolesl eads to formation of privileged structural motifs that can be transformed into diverse scaffoldsi na grochemicals and pharmaceuticals. Despitei ts importance, not many reports are available [18][19][20][21] relative to the numerous reports on substituted 1H-indazoles, [22][23][24][25][26] presumably because of the low reactivity at C3 position of 2H-indazoles [27][28][29] arising from their less aromatic character of quinonoid form [27][28][29] that obstructs formation of functionalized or fused derivatives.Of the functionalized 2H-indazoles, non-arylated scaffolds have been synthesized by C3 alkenylation, [30] annulation, [31] acylation, [27] phosphonylation, [32] nitration, [33] andt rifluoromethylation. [34] However,f ar fewer attempts have been made for the direct arylation of 2H-indazolesa tt he C3 position, including a few reports of Negishic ross-coupling [35] and arylation by aryl halides, [36][37][38][39] which required Cu or Pd metal catalysts, expensive ligands, andmany additives (base, oxidant) with long reaction times (Scheme 1).…”